Ribon Therapeutics
Lexington, US · Founded 2015 · Delaware corporation · 5 employees on LinkedIn · 6 known investors
Founders & leadership
VM
Victoria M. RichonExecutive
Board
CW
Cameron WheelerBoard director
JR
Jonathan RootBoard director
LL
Laurence LaskyBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$119.1M disclosed across 5 rounds · 2015–2022
▶$25MraisedDec 2022 · 1 investors · BiotechnologyRule 506(b)
▶$25MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Laura BrassDirector
- Emma ReeveDirector
- Jonathan RootDirector
- Eyal LifschitzDirector
- Paul BrannellyExecutive Officer
- James AudiaDirector
- Jodie MorrisonDirector
- Cameron WheelerDirector
- Prakash RamanExecutive Officer, Director
- Jeff GoaterDirector
- Gary SuttonExecutive Officer
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25.2MraisedJun 2021 · 16 investors · BiotechnologyRule 506(b)
▶$25.2MraisedJun 2021 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marian NakadaDirector
- Svennilson PeterDirector
- Edward StewartExecutive Officer
- Cameron WheelerDirector
- James AudiaDirector
- Victoria M. RichonExecutive Officer, Director
- Emma ReeveDirector
- Jodie MorrisonDirector
- Laura BrassDirector
- Jonathan RootDirector
- Offering amount
- $60.2M
- Amount sold
- $25.2M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25.4MraisedJan 2019 · 10 investors · BiotechnologyRule 506(b)
▶$25.4MraisedJan 2019 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anja KoenigDirector
- James AudiaDirector
- Marian NakadaDirector
- Svennilson PeterDirector
- Victoria M. RichonExecutive Officer, Director
- Jonathan RootDirector
- Cameron WheelerDirector
- David CordoExecutive Officer
- Offering amount
- $65M
- Amount sold
- $25.4M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$20MraisedOct 2017 · 8 investors · BiotechnologyRule 506(b)
▶$20MraisedOct 2017 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Victoria M. RichonExecutive Officer, Director
- David CordoExecutive Officer
- Cameron WheelerDirector
- Jonathan RootDirector
- Laurence LaskyDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$23.5MraisedNov 2016 · 5 investors · BiotechnologyRule 506(b)
▶$23.5MraisedNov 2016 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cameron WheelerDirector
- Jonathan RootDirector
- Laurence LaskyDirector
- Victoria M. RichonExecutive Officer, Director
- Offering amount
- $23.5M
- Amount sold
- $23.5M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Ribon Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- Who are Ribon Therapeutics's investors?
- Ribon Therapeutics's investors include Avego BioScience Capital, OUP (Osage University Partners), Peregrine Ventures, AbbVie, Novartis Venture Fund, The Column Group.
- How much funding has Ribon Therapeutics raised?
- Ribon Therapeutics has disclosed $119.1M raised across 5 rounds.
- Where is Ribon Therapeutics headquartered?
- Ribon Therapeutics is headquartered in Lexington, US.